Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mesoblast Limited (MESO) vs Unusual Machines Inc. Common Stock (UMAC) Price & Performance

Mesoblast LimitedTrade
Unusual Machines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Mesoblast Limited vs Unusual Machines Inc. Common Stock — how do they compare? Mesoblast Limited trades at $13.76 (market cap $1.83B), while Unusual Machines Inc. Common Stock trades at $17.35 (market cap $971.15M). The key difference: Mesoblast Limited is the larger of the two by market cap, and Unusual Machines Inc. Common Stock is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mesoblast Limited for 15 Days and Unusual Machines Inc. Common Stock for 0 Days on average.

MESOUMAC
Market Cap
$1.83B$971.15M
Volume
259,4453,714,986
Sector
HealthTechnology
52-Week High
$20.96$34.06
52-Week Low
$13.19$7.76
Typical Hold Time
15 Days0 Days
Enterprise Value
$1.91B$657.94M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Mesoblast Limited

MESO trades at $13.895, down 2.63% with bearish technical signals. The company reported substantial revenue growth to $120M in 2026 but remains unprofitable with a net margin of -47.82%. Recent FDA approval for Ryoncil potency assay and completion of Phase 3 back pain trial represent significant milestones. The stock shows mixed sentiment with 45% analyst buy ratings against bearish technical indicators.

While MESO demonstrates strong revenue growth potential and pipeline progress, persistent losses and negative profitability metrics present substantial risk. The company's cash position of $161M provides runway, but investors face volatility from clinical trial outcomes and path to profitability challenges.

Unusual Machines Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MESO

No sentiment data available yet.

UMAC
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO →

About Unusual Machines Inc. Common Stock

Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.

Read more on UMAC →